Minocycline-induced hyperpigmentation of the tongue: successful treatment with the Q-switched ruby laser. 2002

Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
Department of Dermatology, Mount Sinai Medical Center, New York, New York 10009, USA.

BACKGROUND Minocycline-induced hyperpigmentation (MIH) is a benign condition that may persist for years despite abrogation of therapy. The Q-switched ruby laser (QSRL) has been successful in removing such lesions from the skin. To date there is no documentation of QSRL or any laser being used to treat lingual hyperpigmentation associated with minocycline therapy. OBJECTIVE Long-term follow-up results are reported for the use of QSRL to treat lingual hyperpigmentation. The literature is reviewed comparing the use of different laser systems on MIH. METHODS A 26-year-old woman with pigment changes of the tongue and buccal mucosa due to long-term minocycline therapy was treated with four consecutive sessions with QSRL (694 nm, 20-nsec pulse duration, and 6.5 mm spot size) at 3.6-4.0 J/cm2. RESULTS A 90% resolution was achieved after three treatments. After the final treatment the lesions were completely gone. There were no side effects reported. No new pigment was detected at follow-up. CONCLUSIONS Treatment with the QSRL is a safe and effective strategy for treating hyperpigmentation of the tongue associated with minocycline therapy.

UI MeSH Term Description Entries
D008911 Minocycline A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. Akamin,Akne-Puren,Aknemin,Aknin-Mino,Aknosan,Apo-Minocycline,Arestin,Blemix,Cyclomin,Cyclops,Dentomycin,Dynacin,Icht-Oral,Klinomycin,Lederderm,Mestacine,Minakne,Mino-Wolff,Minocin,Minocin MR,Minoclir,Minocycline Hydrochloride,Minocycline Monohydrochloride,Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer,Minolis,Minomycin,Minoplus,Minotab,Minox 50,Mynocine,Akne Puren,Aknin Mino,Apo Minocycline,Hydrochloride, Minocycline,Icht Oral,Mino Wolff,Monohydrochloride, Minocycline
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014060 Tongue Diseases Diseases involving the TONGUE. Microglossia,Disease, Tongue,Diseases, Tongue,Microglossias,Tongue Disease
D017495 Hyperpigmentation Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance. Hypermelanosis,Hypermelanoses

Related Publications

Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
October 1996, Archives of dermatology,
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
October 1996, Archives of dermatology,
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
January 1998, Lasers in surgery and medicine,
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
August 2000, Journal of the American Academy of Dermatology,
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
July 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
August 1996, The British journal of dermatology,
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
March 2022, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
March 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
September 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Ilyse S Friedman, and Ron M Shelton, and Robert G Phelps
January 2023, Photodermatology, photoimmunology & photomedicine,
Copied contents to your clipboard!